ALMOST 80% OF NEW LC DIAGNOSES
ARE IN NEVERSMOKERS OR
PEOPLE WHO QUIT LONG AGO

 

Landscape for Lung Cancer Therapies is Focus of New Post-ASCO MedPredict Report

xray.jpgMedPredict has published a new report in its oncology series entitled “Thought Leader Insight & Analysis: Lung Cancer,” designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in non-small cell and small cell lung cancer.

 

Trackback

 

Leave a Reply